Kathryn Romano, Chief Accounting Officer at Krystal Biotech, Inc. (KRYS), sold 8,804 shares at $175.22 ($1.6M) on 2025-02-27, disclosed to the SEC on 2025-02-28.
Scheduled sale ($1.6M) by Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $176.39 | 2,268 | $400K | 25.5% |
| 2 | $175.22 | 750 | $131K | 8.4% |
| 3 | $179.25 | 2,315 | $415K | 26.5% |
| 4 | $179.25 | 3,471 | $622K | 39.7% |
| Total | $178.17 avg | 8,804 | $1.6M | 100% |
| Filing → |
| KRYS | SELL | 2024-03-01 | $1.8M | — | Filing → |
| KRYS | SELL | 2024-03-01 | $1.4M | — | Filing → |
| KRYS | SELL | 2024-02-28 | $1.1M | — | Filing → |